Compare TECX & RGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TECX | RGR |
|---|---|---|
| Founded | 2019 | 1949 |
| Country | United States | United States |
| Employees | 60 | N/A |
| Industry | | Ordnance And Accessories |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 549.5M | 617.8M |
| IPO Year | N/A | 1994 |
| Metric | TECX | RGR |
|---|---|---|
| Price | $34.54 | $38.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $75.20 | $43.00 |
| AVG Volume (30 Days) | ★ 182.5K | 135.0K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.07% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $546,057,000.00 |
| Revenue This Year | N/A | $2.38 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3,869.00 |
| Revenue Growth | N/A | ★ 1.94 |
| 52 Week Low | $14.39 | $28.33 |
| 52 Week High | $39.53 | $48.21 |
| Indicator | TECX | RGR |
|---|---|---|
| Relative Strength Index (RSI) | 57.62 | 50.68 |
| Support Level | $27.31 | $38.60 |
| Resistance Level | $35.99 | $38.89 |
| Average True Range (ATR) | 2.47 | 0.98 |
| MACD | 0.25 | 0.07 |
| Stochastic Oscillator | 50.14 | 36.12 |
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States, and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.